SAP Founder Invests In Biotechnology From Baden-Wurttemberg, Germany; 22 Million Euros For Tuebingen Biotech Company, CureVac GmbH

TUEBINGEN, Germany--(BUSINESS WIRE)--Feb. 3, 2006--IT pioneer and SAP founder Dietmar Hopp is supporting the future work of biopharmaceutical enterprise CureVac to the tune of 22 million euros through his investment companies DH Capital GmbH & Co. KG and OH Beteiligungen GmbH und Co. KG.

Back to news